血必净注射液对ANP大鼠肠道菌群及肠黏膜屏障功能的影响

doi:10.3969/j.issn.1000-8535.2020.03.004

广州医药 ›› 2020, Vol. 51 ›› Issue (3): 14-20.DOI: 10.3969/j.issn.1000-8535.2020.03.004

血必净注射液对ANP大鼠肠道菌群及肠黏膜屏障功能的影响

黄耀星, 严清青, 苏伟, 何梓健, 罗键雄, 李伟冬, 赵寒冰, 贾林

广州市第一人民医院,华南理工大学附属第二医院(广州 510180)

收稿日期:2020-02-28 出版日期:2020-05-20 发布日期:2021-11-28
通讯作者: 黄耀星,E-mail: huangyaoxing@sina.com
基金资助:
广东省中医药局科研项目(20171191);广东省中医药局科研项目(20161183)

Effect of Xuebijing injection on intestinal flora and intestinal mucosal barrier function in ANP rats

HUANG Yaoxing, YAN Qingqing, SU Wei, HE Zijian, LUO Jianxiong, LI Weidong, ZHAO Hanbing, JIA Lin

Guangzhou First People's Hospital,The Second Affiliated Hospital of South China University of Technology, Guangzhou 510180, China

Received:2020-02-28 Online:2020-05-20 Published:2021-11-28

摘要/Abstract

摘要： 目的探讨血必净注射液对ANP大鼠肠道菌群及肠黏膜屏障功能的影响。方法 40只SD大鼠随机分为空白组、假手术组、ANP组和血必净治疗组(每组10只),空白组不作任何处理,假手术组翻动十二指肠后关腹,ANP组和治疗组用4.5%牛磺胆酸钠溶液胆胰管逆行注射建模,治疗组在建模后经鼠尾静脉注射血必净注射液(3 mL/kg)。24 h后处死大鼠并采样,ELISA法测血AMS、CRP、LPS、TNF-α、IL-6、IL-1β、DAO和D-乳酸等指标,粪菌样本行16SrRNA高通量测序分析,实时定量PCR法检测5种细菌数量,病理检测胰腺和回肠组织,比较各组大鼠的指标。结果 ①ANP组大鼠血AMS升高,CRP、LPS、TNF-α、IL-6、IL-1β、DAO、D-乳酸水平以及胰腺、小肠病理评分均高于空白组和假手术组(P<0.001);②治疗组AMS低于ANP组,血必净可降低上述各种血清指标水平和胰腺、小肠病理评分(P<0.001);③肠道菌群微生态分析显示,血必净可改善ANP大鼠粪菌的丰富度和多样性,缩小与空白组、假手术菌种种类的差异,增加厚壁菌门菌量;治疗组乳酸杆菌、双歧杆菌和普拉梭菌的菌量高于ANP组,肠球菌和大肠埃希的菌量低于ANP组(P<0.001)。结论血必净可增加ANP大鼠肠道菌群的丰富度和多样性,增加有益菌的含量,减少内毒素和促炎因子释放,改善肠黏膜屏障功能。

关键词: 血必净注射液, 急性坏死性胰腺炎, 肠道菌群, 肠黏膜屏障功能

Abstract: Objective To investigate the effect of Xuebijing injection on intestinal flora and intestinal mucosal barrier function in ANP rats. Methods 40 SD rats were randomly divided into blank group, sham operation group, ANP group and Xuebijing treatment group (10 in each group). The sham operation group closed the abdomen after turning the duodenum. The ANP model was established by retrograde injection of 4.5% sodium taurocholate solution into the biliopancreatic duct. Xuebijing injection (3mL/kg) was injected into the tail vein of the rats in the treatment group. 24 hours later, the rats were sacrificed and sampled. AMS, CRP, LPS, TNF-, il-6, il-1, DAO and d-lactic acid were measured by ELISA. The fecal bacteria samples were analyzed by 16SrRNA sequencing technique. Real-time quantitative PCR was used to detect the populations of 5 bacteria in fecal sample. The pathology of pancreas and ileum were examined, and the indexes of rats in each group were compared. Results ①In ANP group, AMS was increased, levels of CRP, LPS, TNF-, il-6, il-1, DAO, d-lactic acid, pancreatic and intestinal pathology scores were higher than those in the blank group and the sham group (P<0.001).②In treatment group,AMS was lower than ANP group, and Xuebijing could reduce the levels of the above factors and scores of pancreatic and intestinal pathology (P<0.001).③ The microecological results of intestinal flora showed that Xuebijing treatment could improve the richness and diversity of fecal bacteria, reduce the difference between Xuebijing group and blank group and sham operation group, and increase the quantity of firmicutes. The amount of Lactobacillus, Bifidobacteria and Clostridium prasei in the Xuebijing group was higher than that in ANP group, while the amount of enterococci and Escherichia coli was lower than that in the ANP group (P<0.001). Conclusion Xuebijing can increase the richness and diversity of intestinal flora, increase the content of beneficial bacteria, reduce the release of endotoxin and pro-inflammatory factors, and improve the intestinal mucosal barrier function in ANP rats.

Key words: Xuebijing injection, Acute necrotizing pancreatitis, Intestinal flora, Intestinal mucosal barrier function

黄耀星, 严清青, 苏伟, 何梓健, 罗键雄, 李伟冬, 赵寒冰, 贾林. 血必净注射液对ANP大鼠肠道菌群及肠黏膜屏障功能的影响[J]. 广州医药, 2020, 51(3): 14-20.

HUANG Yaoxing, YAN Qingqing, SU Wei, HE Zijian, LUO Jianxiong, LI Weidong, ZHAO Hanbing, JIA Lin. Effect of Xuebijing injection on intestinal flora and intestinal mucosal barrier function in ANP rats[J]. Guangzhou Medical Journal, 2020, 51(3): 14-20.

参考文献

[1] 温聪聪,王颖,吴德卿,等. 重症急性胰腺炎胃肠功能障碍的诊治和发生机制研究进展[J]. 中华胰腺病杂志,2019,19(2):143-145.
[2] 欧娅,黄耀星,苏伟,等. 血必净注射液对SAP大鼠TLR4信号通路介导肠黏膜屏障功能障碍的影响[J]. 广州医药,2019,50(3):1-5.
[3] 邱嘉华,陈奕金,贾林,等. 牛黄胆酸钠诱导急性坏死性胰腺炎大鼠模型的理想浓度[J]. 中华胰腺病学杂志, 2010,10(2):120-123.
[4] SCHMIDT J, RATTER D W, LEWANDROWSKI K, et al. A better model of acute pancreatitis for evaluating therapy[J]. Ann Surg, 1992,215(1):44-56.
[5] CHIU C J, MCARDLE A H, BROWN R, et al. Intestinal mucosal lesion in low-flow states a morphological, hemodynamic, and metabolic reappraisal[J]. Arch Surg, 1970,101(4):478-483.
[6] 陈辉,兰涛.肠黏膜屏障功能障碍在重症急性胰腺炎中的研究进展[J]. 中华实验和临床感染病杂志(电子版),2016,10(6):659-662.
[7] THURSBY E,JUGE N. Introduction to the human gut microbiota[J]. Biochem J, 2017,474(11):1823-1836.
[8] ROMOND M B,COLAVIZZA M,KALACH N,et al. Does the intestinal bifidobacterial colonisation'affect bacterial translocation[J]. Anaerobe, 2008,14(1):43-48.
[9] TAN C, LING Z, HUANG Y, et al. Dysbiosis of intestinal microbiota associated with inflammation involved in the progression of acute pancreatitis[J]. Pancreas, 2015, 44(6):868-875.
[10] QIN H L, ZHENG,J J, TONG,D N, et al. Effect of Lactobacillus plantarum enteral feeding on the gut permeability and septic complications in the patients with acute pancreatitis.[J]. Eur J Clin Nutr,2008,62(7):923-930.
[11] ZHU Y, HE C, LI X, et al. Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice[J]. J Gastroenterol, 2019,54(4):347-358.
[12] BESSELINK M G. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial[J]. Lancet, 2008,371(9613):651-659.
[13] HUANG H, JI L, SONG S, et al. Identification of the major constituents in Xuebijing injection by HPLC-ESI-MS[J]. Phytochem Anal, 2011,22(4):330-338.
[14] XIAO S H, LUO L, LIU X H, et al. Curative efficacy and safety of traditional Chinese medicine xuebijing injections combined with ulinastatin for treating sepsis in the Chinese population: a meta-analysis[J]. Med,2018,97(23): e10971.
[15] WANG L, LIU Z, DONG Z, et al. Effects of Xuebijing injection on microcirculation in septic shock[J]. J Surg Res,2016,202(1):147-154.
[16] 苏伟,欧娅,杨智,等. 血必净注射液对重症急性胰腺炎大鼠肠黏膜屏障损伤的实验疗效[J]. 广州医学院学报, 2012,40(5):1-3.
[17] 黄奕云,苏伟,林明,等. 血必净对SAP大鼠TLR9信号通路调控肠黏膜炎症反应机制的影响[J]. 中国处方药, 2014,12(7):15-17.
[18] 满意,常加伟,汤亲青.重症急性胰腺炎不同病程的细菌移位及肠道菌群组成结构的变化研究[J]. 中国急救医学, 2019,39(1):71-76.

血必净注射液对ANP大鼠肠道菌群及肠黏膜屏障功能的影响

Effect of Xuebijing injection on intestinal flora and intestinal mucosal barrier function in ANP rats

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

编辑推荐

Metrics

本文评价

[1]	罗梅娟, 胡家奇, 魏颖, 欧巧群, 王丽娜, 张又祥. 低出生体重早产儿应用抗生素后的肠道菌群动态变化[J]. 广州医药, 2021, 52(3): 61-67.
[2]	欧娅, 黄耀星, 苏伟, 罗键雄, 陈伟明, 唐翔, 陈泳华, 张婷婷. 血必净注射液对SAP大鼠TLR4信号通路介导肠黏膜屏障功能障碍的影响[J]. 广州医药, 2019, 50(3): 1-5.